Zagidullin, N,
Ruslan, G,
Anton, T,
Paruir, D,
Sergey, D,
Irina, L,
Valentin, P (2022) SERUM BIOMARKERS IN
MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA
STARODUBOV, V.I.,
MARCZAK, L.B.,
VARAVIKOVA, E.,
BIKBOV, B.,
ERMAKOV, S.P.,
GALL, J.,
GLENN, S.D.,
GRISWOLD, M.,
IDRISOV, B.,
KRAVCHENKO, M.,
LIOZNOV, D.,
LOYOLA, E.,
RAKOVAC, I.,
VLADIMIROV, S.K.,
VLASSOV, V.,
MURRAY, C.J.L.,
NAGHAVI, M (2018) , and Risk Factors Study 2016
(GBD 2016) to evaluate trends in
mortality, causes of death, years lived
Zhou, Qi,
Zhang, Daming,
Chen, Xin,
Yang, Zhao,
Liu, Zhihui,
Wei, Baixing,
Jin, Mei,
Feng, Kairu,
Guo, Chunmei,
Sun, Junying,
Chen, Sheng,
Zhang, Ruijia,
Piao, Xiai,
Gareev, Ilgiz,
Sun, Zhenying,
Wang, Xiaoxiong,
Li, Lili,
Zhao, Shiguang,
Yang, Guang (2020) . An ICH outcome score combining D-dimer level for evaluating poor functional outcome and
mortalityMotloch, LJ;,
Jirak, P;,
Gareeva, D;,
Davtyan, P;,
Gumerov, R;,
Lakman, I;,
Tataurov, A;,
Zulkarneev, R;,
Kabirov, I;,
Cai, BZ;,
Valeev, B;,
Pavlov, V;,
Kopp, K;,
Hoppe, UC;,
Lichtenauer, M;,
Fiedler, L;,
Pistulli, R;,
Zagidullin, N (2022) -discharge
mortality of patients with COVID-19 pneumonia.
Methods: Serum soluble ST2, VCAM-1, and hs-TnI were
Evdakov, V.A.,
Starodubov, V.I.,
Oleynik, B.A.,
Sharafutdinova, N.Kh.,
Borisova, M.V.,
Plechev, V.V. (2023) ) on
mortality from this disorder. Objective. To investigate the correlation between number of patients with CHD
in the formation of
general professional and professional com-petencies, as well as for the adaptation of students
on the development of chronic
generalized catarrhal gingivitis, to suggest a treatment regimen using a complex